Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Liraglutide to Prevent Postoperative Delirium in Elderly Cardiac Surgery Patients
ChiCTR2500106943Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jul 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of liraglutide in postoperative delirium (POD), post-operative cognitive decline (POCD), anxiety disorder and 4 more (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Incidence of postoperative delirium within 7 days. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
03
Conditions
postoperative delirium (POD)post-operative cognitive decline (POCD)anxiety disordermajor depressive disorder (MDD)sleep disorder
Beyond the preview
Go deeper on ChiCTR2500106943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106943.